KKR & Co Inc
F:KR51
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
KKR & Co Inc
F:KR51
|
US |
|
V
|
Verona Pharma PLC
F:I9SA
|
UK |
|
M
|
MAG Silver Corp
XMUN:MQ8
|
CA |
|
Microport Scientific Corp
F:MSK
|
CN |
|
Reitmans Canada Ltd
OTC:RTMNF
|
CA |
|
C
|
China Longyuan Power Group Corp Ltd
F:6WX
|
CN |
|
I
|
Inogen Inc
F:6IO
|
US |
|
M
|
Mena Transport PCL
SET:MENA
|
TH |
|
B
|
Boyd Gaming Corp
XBER:BO5
|
US |
|
S
|
Sembcorp Industries Ltd
XMUN:SBOA
|
SG |
|
G
|
Globe Trade Centre SA
XMUN:G91
|
PL |
Wall St Price Targets
KR51 Price Targets Summary
KKR & Co Inc
According to Wall Street analysts, the average 1-year price target for
KR51 is 130.72 EUR with a low forecast of 105.7 EUR and a high forecast of 164.83 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KR51's stock price target?
Price Target
130.72
EUR
According to Wall Street analysts, the average 1-year price target for
KR51 is 130.72 EUR with a low forecast of 105.7 EUR and a high forecast of 164.83 EUR.
What is the Revenue forecast for KKR & Co Inc?
Projected CAGR
-12%
Over the last 14 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 3 years is -12%.
What is the Operating Income forecast for KKR & Co Inc?
Projected CAGR
5%
The compound annual growth rate for Operating Income over the next 8 years is 5%.
What is the Net Income forecast for KKR & Co Inc?
Projected CAGR
25%
Over the last 14 years, the compound annual growth rate for Net Income has been 66%. The projected CAGR for the next 8 years is 25%.